![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
Previous Article | Next Article 
Infection and Immunity, September 2002, p. 4961-4967, Vol. 70, No. 9
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.9.4961-4967.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Immunochemistry and Biochemical Microbiology,1 Department of Immunology and Cell Biology, Research Center Borstel, D-23845 Borstel, Germany2
Received 10 January 2002/ Returned for modification 25 March 2002/ Accepted 11 June 2002
 |
ABSTRACT |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
) secretion irrespective of the virulence of the M. avium isolate used for infection, revealing that TNF- could have been only partially responsible for the control of intracellular M. avium growth. In conclusion, ERK1/2- and TNF--independent pathways are sufficient to limit intramacrophage growth of less-virulent M. avium strains, but early ERK1/2 activation in infected macrophages is critically involved in controlling the growth of highly replicative M. avium strains. |
INTRODUCTION |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Infections with mycobacteria, such as tuberculosis, are characterized by their chronic course. Both human and mouse studies have provided ample evidence that even in the face of an adequate immune response, mycobacteria like Mycobacterium tuberculosis and Mycobacterium avium are able to persist inside macrophages (13; reviewed in reference 20). Of interest, several strains and distinct morphotypes (smooth transparent, smooth opaque) of M. avium differ with respect to virulence and persistence in an in vivo infection model (25). One potential mechanism by which virulent mycobacterial strains, as opposed to avirulent strains, may achieve a state of long-term persistence is the modulation of signaling cascades leading to macrophage activation (reviewed in reference 23).
Diverse signaling cascades are involved in triggering cellular responses to pathogenic organisms (reviewed in reference 22). One essential branch of cell signaling in eucaryotic organisms is the ubiquitously expressed family of mitogen-activated protein (MAP) kinases (reviewed in reference 7). These serine/threonine kinases are critically involved in cell proliferation, differentiation, and cell death, as well as the inflammatory response (reviewed in reference 17). In mammals there are three subfamilies of MAP kinases that can be activated independently and simultaneously: p46 and p54 c-Jun-NH2-terminal kinases, p42 and p44 extracellular signal-regulated kinases 1 and 2 (ERK1/2), and p38 MAP kinase (reviewed in reference 5). MAP kinases mediate cellular responses to a variety of extracellular stimuli, such as physical stress (e.g., osmotic changes), inflammatory cytokines, growth factors, and bacterial components (e.g., lipopolysaccharide [LPS]) (reviewed in reference 18). Highly specific, cell-permeable inhibitors of MAP kinase activity have been useful tools in identifying some physiological functions of these signaling cascades in terms of infectious processes. By using these inhibitors, the life cycles of some viruses, e.g., human immunodeficiency virus, were determined to depend on ERK1/2 and p38 MAP kinase activity (29, 32, 34). ERK1/2 activity was also shown to be critically involved in invasion of the facultative intracellular bacterium Listeria monocytogenes, but not Salmonella enterica serovar Typhimurium (31). Even growth of some tumors in vivo was successfully blocked by MAP kinase inhibitors (28).
The activation of MAP kinase signaling cascades by mycobacterial components (6, 15) as well as viable M. avium (26) has only recently been described. However, the functional relevance of MAP kinase activity with respect to uptake and intracellular persistence of mycobacteria has remained unexplored. In particular, it is unknown whether there is a direct correlation between the magnitude of MAP kinase activation and the magnitude of intracellular replication of different M. avium strains or morphotypes. In this study, we investigated whether highly specific MAP kinase inhibitors would interfere with intramacrophage growth and cytokine induction of M. avium strains differing in their in vitro replication rates.
|
MATERIALS AND METHODS |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Inhibitors. PD98059 and SB203580 were purchased from Calbiochem (Schwalbach, Germany) and used at concentrations of 3 or 10 µM. Dimethyl sulfoxide (DMSO; Sigma) was added to cultures at 0.1% (vol/vol) as solvent control.
Isolation and cultivation of human monocyte-derived macrophages. Mononuclear cells were isolated from the peripheral blood of healthy volunteers by density gradient centrifugation (4). Lymphocytes and monocytes were separated by counterflow elutriation as previously described (12). Highly purified (consistently >95%) monocytes were cultivated for 7 days in Teflon culture bags (CellGenix, Freiburg, Germany) in RPMI 1640 (Biochrom, Berlin, Germany) in the presence of 2% (vol/vol) heat-inactivated human AB serum, 2 ng of human macrophage colony-stimulating factor (R&D Systems, Wiesbaden, Germany) per ml, 2 mmol of L-glutamine (Biochrom) per liter, 100 U of penicillin G per ml, and 100 µg of streptomycin/ml (both from Biochrom). Cell viability was determined by trypan blue staining. Macrophages were phenotyped by cell surface marker expression profile (CD14, macrophage mannose receptor, carboxypeptidase M, and HLA-DR) as described previously (26). Macrophages were cultivated in 24-well flat-bottom microtiter plates (Nunc, Roskilde, Denmark) in RPMI 1640 containing 10% (vol/vol) heat-inactivated fetal calf serum (Biochrom) and 2 mmol of L-glutamine/liter. Cultures were incubated at 37°C in a humidified atmosphere containing 5% CO2.
In vitro infection. A total of 2.5 x 105 human macrophages (at a concentration of 5 x 105 per ml) were inoculated with 1.25 x 106 CFU of M. avium 2151 SmT or 2151 SmO per well, and cultures were incubated in the presence or absence of MAP kinase inhibitors. After 4 h, cells were washed vigorously with warm Hank's balanced salt solution to remove extracellular bacteria. To determine bacterial uptake, macrophages were lysed by addition of 0.1% saponin. Lysates were serially diluted and plated on agar (see above). For the investigation of bacterial growth, parallel cultures were maintained for 7 days in 500 µl of medium (at day three, 500 µl of fresh medium was added). Subsequently, cells were washed, lysed, diluted, and plated for CFU determination as described above. In several experiments donor-dependent detachment of macrophages was noted to a varying degree after 7 days of infection. To take into account potential differences in the survival rates of macrophages infected with mycobacterial strains of different virulences under different assay conditions, the actual amount of mycobacteria inside macrophages still present at the end of culture was determined. To this end, adherent macrophages were quantified at the end point of infection as follows: in each well, two identical areas (each 2 mm2 in size) equidistant from the center of the well (1 mm above and 1 mm below) were defined using a superimposed grid. Within any one individual well, these two indicator areas showed comparable densities and distributions of macrophages. Using a digital camera (Visicam 1300; Vitron Systems GmbH, Munich, Germany) attached to a microscope (DMIRB, Leica Microsystems AG, Wetzlar, Germany) and imaging software (MetaMorph 3.0; Universal Imaging, West Chester, Pa.), the indicator areas were photographed and macrophages present in these areas were counted manually on printouts. Subsequently, CFU counts per well were divided by the mean number of macrophages in these indicator areas. This index allows direct comparison of mycobacteria surviving within macrophages of different wells and defines the relative CFU, shown below in Fig. 1 and 3.
|
|
Detection of cytokine release.
A total of 4 x 105 human macrophages (at a concentration of 8 x 105 per ml) were stimulated with 2 x 106 CFU of M. avium or 10 ng of LPS/ml as a control. Culture supernatants of stimulated macrophages were harvested at the time points indicated and stored at -20°C until analysis. Sandwich enzyme-linked immunosorbent assays (ELISAs) were used for detecting tumor necrosis factor alpha (TNF-; H. Gallati, Intex, Muttenz, Switzerland) (11) and interleukin-10 (IL-10) (R&D Systems) in culture supernatants. Assays were performed as recommended by the manufacturers.
Statistical analysis.
The effects of p38 and ERK inhibition on intramacrophage mycobacterial replication and cytokine secretion were analyzed in infection experiments with six and three different donors, respectively. For statistical analysis, data from independent infection experiments were log transformed prior to analysis. Two-factorial analysis of variance with the donor as blocking factor and subgroup analysis were performed by using a one-sided t test (JMP 4.0; SAS Institute, Cary, N.C.). The -error was corrected according to the Bonferroni-Holm procedure. Cytokine concentrations under different culture conditions were correlated to concentrations in control cultures (normalized to 100%). Data obtained from independent experiments were compared by using a t test for multiple comparisons and are represented as the mean ± standard deviation (SD).
|
RESULTS |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
M. avium-induced MAP kinase activation is inversely correlated to in vitro virulence of the M. avium morphotypes. In order to investigate whether the divergent intracellular replication rates of the two morphotypes were related to differential host cell activation, M. avium was added to human macrophage cultures and phosphorylation of the p38 and ERK1/2 (p44/p42) MAP kinases was analyzed. In macrophages infected with the highly replicative SmT morphotype, only a weak phosphorylation of both p38 and ERK1/2 was observed. In contrast, a markedly stronger signal of p38 and ERK1/2 phosphorylation was detected after addition of the poorly persisting SmO morphotype to the macrophages (Fig. 2). Both M. avium morphotypes induced p38 and ERK1/2 phosphorylation with identical kinetics, starting with detectable phosphorylation as early as 15 min (data not shown) and with a maximum at 30 to 45 min. Thus, the magnitude of MAP kinase phosphorylation induced by M. avium was inversely correlated to intracellular mycobacterial replication.
|
The presence of MAP kinase inhibitors did not significantly affect mycobacterial uptake into macrophages 4 h postinfection compared to cultures with no additive or with DMSO as solvent control (data not shown). After 7 days, CFU of the highly replicative SmT morphotype had substantially increased in cultures containing PD98059 (10 µM), whereas the presence of SB203580 did not have any effect even at concentrations up to 10 µM. The gradual elimination of the SmO morphotype from macrophages was unaffected after coincubation with either PD98059 or SB203580 (Fig. 3A). In order to validate the observed growth-enhancing effect of PD98059 on the highly replicative variant 2151 SmT, parallel cultures were infected with another strain of M. avium (SE01) which also showed extensive growth in macrophages. Again, the presence of PD98059 led to an increase in mycobacterial CFU relative to macrophage numbers, while SB203580 did not alter intracellular growth of this strain (Fig. 3B). DMSO alone had no influence on mycobacterial growth. In addition, a direct effect of PD98059 and SB203580 on mycobacterial growth was excluded by cultivation of mycobacteria in the presence of MAP kinase inhibitors but in the absence of macrophages (data not shown).
The same set of experiments was performed independently for six different donors. Although there was substantial donor-dependent variation with regard to the extent of mycobacterial proliferation within macrophages, the presence of PD98059 led to a significant increase in colony counts of the highly proliferative strains 2151 SmT (Fig. 3C) and SE01 (Fig. 3D). These results were confirmed by using a second, more potent MEK-1 inhibitor, U0126 (data not shown). In contrast, the presence of PD98059 did not significantly alter CFU counts of the SmO morphotype, and mycobacterial growth was repressed in all cases (Fig. 3C). The presence of SB203580 consistently had no significant effect on intramacrophage replication rates of any of the M. avium strains tested (Fig. 3C and D).
Therefore, activation of the ERK1/2 pathway seems to be critically involved in controlling intracellular mycobacterial replication of highly replicative M. avium strains.
Cytokines are only partially involved in control of intramacrophage growth of M. avium.
To gain further insight into the mechanisms by which inhibition of the ERK1/2 pathway might exert its intramacrophage growth-promoting effect on certain M. avium strains, the magnitude of cytokine secretion induced by M. avium strains differing in their virulence was analyzed in the presence and absence of MAP kinase inhibitors. To this end, human macrophages were infected with M. avium 2151 SmT or SmO and the levels of the macrophage-activating cytokine TNF- and the macrophage-deactivating cytokine IL-10 into the supernatant were analyzed. Both M. avium morphotypes induced the release of TNF- and IL-10 in a dose-dependent manner (Fig. 4). The highly replicative SmT morphotype, which led to only a weak MAP kinase activation, induced the release of significantly smaller amounts (up to three times less than SmO) of TNF- and IL-10. In contrast, the SmO morphotype, a strong activator of MAP kinases, led to a strong induction of cytokine release. Therefore, M. avium-induced TNF- and IL-10 release reflected the extent of MAP kinase activation by morphotypes differing in their intracellular replication rates in vitro.
|
and IL-10 secretion. Our data (Fig. 5) clearly show, however, that the effect of MAP kinase inhibition on cytokine expression was not virulence specific. In fact, a differential effect of MAP kinase inhibition on TNF- and IL-10 secretion, previously demonstrated by our laboratory for M. avium strain SE01 (26), was seen for both morphotypes of strain 2151 and was, therefore, independent of the virulence of the M. avium isolate. TNF- release was significantly reduced by PD98059 in a dose-dependent manner after stimulation with either M. avium strain. In contrast, IL-10 formation was not inhibited in the presence of PD98059 (Fig. 5A). Inhibition of p38 activity by cocultivation with SB203580 did not reduce TNF- formation in macrophages induced by either morphotype. Although statistically not significant, M. avium-induced TNF- release was usually enhanced. Strain 2151 SmT always induced little IL-10 formation (Fig. 4). Usage of SB203580 further reduced IL-10 release, although effects were not found to be statistically significant because all measured IL-10 amounts were near the lower detection limit of the ELISA (Fig. 5B). The highly activating smooth opaque morphotype induced the formation of higher amounts of IL-10. In this case, IL-10 release was significantly reduced in the presence of SB203580 (Fig. 5B).
|
|
DISCUSSION |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
formation, whereas p38 activity, but not the ERK1/2 pathway, was involved in IL-10 release. Infection with M. avium, a facultative intracellular opportunistic pathogen in humans, is a well-studied model for mycobacterial infections. A major phenotypic characteristic of M. avium isolates is their ability to appear in different colony morphotypes: smooth (either transparent or opaque) or rough (reviewed in reference 14). Although morphotypes of the same strain are very closely related, previous studies demonstrated that the smooth transparent variant is usually better able to survive and grow intracellularly than the opaque morphotype (10, 21). With regard to the M. avium morphotypes used in this study (2151 SmT and SmO), this pattern has been confirmed both in murine macrophages and in a mouse model of infection (1, 2). Our results extend these findings to human monocyte-derived macrophages. This is not trivial, because in the case of the M. tuberculosis strain H37Rv and its avirulent variant H37Ra, growth patterns in mice and murine macrophages are not reflected by their in vitro growth characteristics in human macrophages (24). Why different morphotypes of M. avium either possess or lack the capacity for intracellular persistence is entirely unknown, but the responsible mechanisms likely involve modulation of intracellular signaling pathways (reviewed in reference 23).
Focusing on MAP kinase signaling events, we observed activation of both ERK1/2 and p38 in response to the two closely related morphotypes of M. avium 2151. Since the magnitude of MAP kinase activation was inversely correlated to the intramacrophage replication potential of these strains, we hypothesized that ERK1/2 and p38 signaling might indeed play a direct role in controlling the growth of these strains.
A variety of commercially available compounds have proven to be powerful tools for functional analysis of particular cell signaling elements (8). The highly specific inhibitors PD98059 and SB203580 have previously been used to demonstrate involvement of ERK1/2 and p38 MAP kinase pathways in uptake and persistence of pathogenic viruses and bacteria (16, 29).
Regarding intracellular mycobacterial replication, inhibition of the ERK1/2 pathway led to an increased growth of M. avium 2151 SmT (and also of another, highly replicative strain, SE01) within human macrophages. This growth-enhancing effect was, however, not observed for the related SmO morphotype of the same strain. These data indicate that replication of some mycobacterial strains, such as M. avium 2151 SmO, can easily be controlled by macrophages, even in the presence of drugs interfering with essential signaling pathways. In this respect, it is interesting that ERK1/2 activity also seems not to be involved in controlling the replication of another facultative intracellular bacterium, L. monocytogenes (16). In contrast, other mycobacterial variants, like M. avium 2151 SmT and SE01, are more resistant to growth control by the macrophage. In macrophages infected with these strains, additional repression of the ERK1/2 pathway might unbalance innate defense mechanisms to an extent more favorable to mycobacterial replication. Notably, inhibition of p38 activity in human macrophages did not significantly affect intracellular replication of any of the M. avium variants used. From these results, we conclude that p38 activity is not critically involved in the control of mycobacterial growth in infected macrophages in vitro. Parallel infection studies performed in bone marrow-derived macrophages of C57BL/6 mice (A. Blumenthal et al., unpublished observations) corroborate our data and show that our results are not restricted to the human system.
One possible mechanism by which the magnitude of MAP kinase activity may influence intracellular mycobacterial replication could be the induction of cytokines. With regard to TNF-, several previous studies have shown an inverse correlation between the extent of TNF- release in reaction to M. avium and the virulence of the infecting strain or morphotype. Therefore, the hypothesis was put forth that certain M. avium isolates are more virulent because they induce only little TNF- in vitro (10, 27). With respect to the two morphotypes of M. avium 2151, our data confirm this hypothesis and, in addition, provide a plausible explanation at the signal transduction level. Thus, the virulent morphotype induced less MAP kinase phosphorylation than the avirulent morphotype. Virulence may therefore simply be a reflection of an intrinsic inability of certain mycobacterial strains to stimulate macrophages. However, it is intriguing to speculate that virulence may also reside in the capacity of some mycobacterial strains to inhibit early signal transduction events, such as MAP kinase phosphorylation.
PD98059 and SB203580 were used to analyze whether MAP kinase activation would affect M. avium-induced cytokine release in a virulence-dependent way. As shown, independent of the morphotype used, TNF- production was critically dependent on the activation of the ERK1/2 pathway, whereas p38 activity, and not ERK1/2, was involved in IL-10 release, which corroborates earlier studies using another well-replicating M. avium strain, SE01 (26).
We suggest that differential regulation of pro- and antiinflammatory mediators at the level of MAP kinase activity may represent a general macrophage response to M. avium (independent of the strain or morphotype) and, possibly, to other virulent and avirulent mycobacterial species.
Previous studies described contradictory effects of neutralization of endogenous IL-10 in vitro (9, 30). In our system, inhibition of endogenous IL-10 by SB203580 was not accompanied by enhanced growth of any M. avium strain tested. We conclude that IL-10 release by infected macrophages may not be critical in intracellular growth control of M. avium. Inhibition of the ERK1/2 signaling cascade in M. avium 2151 SmT- or SE01-infected macrophages was followed by diminished TNF- release and enhanced intracellular mycobacterial replication. An important role for TNF- in the control of M. avium replication in vitro has previously been demonstrated (1). Furney et al. (10) showed a significant inhibitory effect of TNF- on intracellular replication only for extensively replicating M. avium variants, whereas the effect on low-level-replicating mycobacteria was minimal. Thus, early inhibition of TNF- release may be one of the mechanisms by which PD98059 promotes intramacrophage growth of some highly replicative strains of M. avium.
A number of arguments, however, strengthen the view that control of M. avium replication insides macrophages involves more than stimulation by TNF-. First, infection of macrophages with M. avium SE01 induces TNF- levels comparable to those achieved by the easily controlled 2151 SmO (26; also data not shown). Yet, SE01 is a highly replicative M. avium strain and, in this respect, quite similar to 2151 SmT, which induces only low amounts of TNF-. Second, inhibition of the ERK1/2 pathway markedly reduced TNF- secretion induced by 2151 SmO, yet intracellular survival rates stayed low for this isolate.
Since the growth-enhancing effect of ERK1/2 pathway inhibition cannot be entirely explained by modulation of TNF- levels, it would appear that M. avium-induced activation of the ERK1/2 signaling cascade is involved in other, TNF--independent cellular processes that ultimately lead to restriction of mycobacterial growth. Alternatively, it is entirely possible that M. avium strains simply differ in their susceptibility to TNF--induced bacteriostatic mechanisms and that, for some strains, higher TNF- levels are required to achieve growth inhibition than for others.
Our present study demonstrates that, for M. avium infection, the relationship between macrophage activation (as reflected by MAP kinase phosphorylation), TNF- and IL-10 secretion, and bacteriostasis is more complex than previously thought. We have identified ERK1/2 signaling as a critical pathway for growth restriction of some M. avium strains. We further uncovered that ERK1/2-independent mechanisms, as well as TNF--independent mechanisms, must exist to curtail the growth of other M. avium variants. It would appear that novel strategies for antimycobacterial immunotherapy will require a more thorough understanding of the subtleties of the host-pathogen relationship.
|
ACKNOWLEDGMENTS |
|---|
This work was supported in part by the Deutsche Forschungsgemeinschaft, SFB 415, project C7.
|
FOOTNOTES |
|---|
|
REFERENCES |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
| 1. | Appelberg, R., and I. M. Orme. 1993. Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages. Immunology 80:352-359.[Medline] |
| 2. | Appelberg, R., A. Sarmento, and A. G. Castro. 1995. Tumour necrosis factor-alpha (TNF-alpha) in the host resistance to mycobacteria of distinct virulence. Clin. Exp. Immunol. 101:308-313.[Medline] |
| 3. | Belisle, J. T., K. Klaczkiewicz, P. J. Brennan, W. R. J. Jacobs, and J. M. Inamine. 1993. Rough morphological variants of Mycobacterium avium. Characterization of genomic deletions resulting in the loss of glycopeptidolipid expression. J. Biol. Chem. 268:10517-10523. |
| 4. | Bøyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Investig. Suppl. 97:77-89. |
| 5. | Cano, E., and L. C. Mahadevan. 1995. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20:117-122.[CrossRef][Medline] |
| 6. | Chan, E. D., K. R. Morris, J. T. Belisle, P. Hill, L. K. Remigio, P. J. Brennan, and D. W. Riches. 2001. Induction of inducible nitric oxide synthase-NO by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF- B signaling pathways. Infect. Immun. 69:2001-2010. |
| 7. | Chang, L., and M. Karin. 2001. Mammalian MAP kinase signalling cascades. Nature 410:37-40.[CrossRef][Medline] |
| 8. | Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95-105.[CrossRef][Medline] |
| 9. | Denis, M., and E. Ghadirian. 1993. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J. Immunol. 151:5425-5430.[Abstract] |
| 10. | Furney, S. K., P. S. Skinner, A. D. Roberts, R. Appelberg, and I. M. Orme. 1992. Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor. Infect. Immun. 60:4410-4413. |
| 11. | Gallati, H., and I. Pracht. 1985. Horseradish peroxidase: kinetic studies and optimization of peroxidase activity determination using the substrates H2O2 and 3,3',5,5'-tetramethylbenzidine. J. Clin. Chem. Clin. Biochem. 23:453-460.[Medline] |
| 12. | Grage-Griebenow, E., D. Lorenzen, R. Fetting, H.-D. Flad, and M. Ernst. 1993. Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur. J. Immunol. 23:3126-3135.[Medline] |
| 13. | Hänsch, H. C., D. A. Smith, M. E. Mielke, H. Hahn, G. J. Bancroft, and S. Ehlers. 1996. Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells. Int. Immunol. 8:1299-1310. |
| 14. | Inderlied, C. B., C. A. Kemper, and L. E. Bermudez. 1993. The Mycobacterium avium complex. Clin. Microbiol. Rev. 6:266-310. |
| 15. | Jones, B. W., T. K. Means, K. A. Heldwein, M. A. Keen, P. J. Hill, J. T. Belisle, and M. J. Fenton. 2001. Different Toll-like receptor agonists induce distinct macrophage responses. J. Leukoc. Biol. 69:1036-1044. |
| 16. | Kugler, S., S. Schuller, and W. Goebel. 1997. Involvement of MAP-kinases and -phosphatases in uptake and intracellular replication of Listeria monocytogenes in J774 macrophage cells. FEMS Microbiol. Lett. 157:131-136.[Medline] |
| 17. | Kyriakis, J. M., and J. Avruch. 1996. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271:24313-24316. |
| 18. | Kyriakis, J. M., and J. Avruch. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:807-869. |
| 19. | MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.[CrossRef][Medline] |
| 20. | Manabe, Y. C., and W. R. Bishai. 2000. Latent Mycobacterium tuberculosis—persistence, patience, and winning by waiting. Nat. Med. 6:1327-1329.[CrossRef][Medline] |
| 21. | Meylan, P. R., D. D. Richman, and R. S. Kornbluth. 1990. Characterization and growth in human macrophages of Mycobacterium avium complex strains isolated from the blood of patients with acquired immunodeficiency syndrome. Infect. Immun. 58:2564-2568. |
| 22. | Muzio, M., G. Natoli, S. Saccani, M. Levrero, and A. Mantovani. 1998. The human Toll signaling pathway: divergence of nuclear factor B and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187:2097-2101. |
| 23. | Nandan, D., K. L. Knutson, R. Lo, and N. E. Reiner. 2000. Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis. J. Leukoc. Biol. 67:464-470.[Abstract] |
| 24. | Paul, S., P. Laochumroonvorapong, and G. Kaplan. 1996. Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. J. Infect. Dis. 174:105-112.[Medline] |
| 25. | Pedrosa, J., M. Florido, Z. M. Kunze, A. G. Castro, F. Portaels, J. McFadden, M. T. Silva, and R. Appelberg. 1994. Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice. Clin. Exp. Immunol. 98:210-216.[Medline] |
| 26. | Reiling, N., A. Blumenthal, H. D. Flad, M. Ernst, and S. Ehlers. 2001. Mycobacteria-induced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity. J. Immunol. 167:3339-3345. |
| 27. | Sarmento, A. M., and R. Appelberg. 1995. Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor alpha production in infected mice and in in vitro-cultured mouse macrophages. Infect. Immun. 63:3759-3764.[Abstract] |
| 28. | Sebolt-Leopold, J. S., D. T. Dudley, R. Herrera, K. Van Becelaere, A. Wiland, R. C. Gowan, H. Tecle, S. D. Barrett, A. Bridges, S. Przybranowski, W. R. Leopold, and A. R. Saltiel. 1999. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5:810-816.[CrossRef][Medline] |
| 29. | Shapiro, L., K. A. Heidenreich, M. K. Meintzer, and C. A. Dinarello. 1998. Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro. Proc. Natl. Acad. Sci. USA 95:7422-7426. |
| 30. | Shiratsuchi, H., B. Hamilton, Z. Toossi, and J. J. Ellner. 1996. Evidence against a role for interleukin-10 in the regulation of growth of Mycobacterium avium in human monocytes. J. Infect. Dis. 173:410-417.[Medline] |
| 31. | Tang, P., C. L. Sutherland, M. R. Gold, and B. B. Finlay. 1998. Listeria monocytogenes invasion of epithelial cells requires the MEK-1/ERK-2 mitogen-activated protein kinase pathway. Infect. Immun. 66:1106-1112. |
| 32. | Yang, X., Y. Chen, and D. Gabuzda. 1999. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-B. J. Biol. Chem. 274:27981-27988. |
| 33. | Zwilling, B. S., and T. K. Eisenstein. 1993. Macrophage-pathogen interactions. Marcel Dekker Inc., New York, N.Y. |
| 34. | Zybarth, G., N. Reiling, H. Schmidtmayerova, B. Sherry, and M. Bukrinsky. 1999. Activation-induced resistance of human macrophages to HIV-1 infection in vitro. J. Immunol. 162:400-406. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|
) numbers in indicator areas were determined. (C) To meaningfully compare actual intracellular mycobacterial replication rates within macrophages, CFU were correlated to macrophage numbers at day 7. Relative CFU were calculated by dividing CFU per well by the number of macrophages in indicator areas (as described in Materials and Methods). Means of duplicates ± SD of one typical experiment out of six (six different donors) are shown.
) or 0.1% (vol/vol) DMSO as solvent control for 60 min. Macrophages were infected with M. avium 2151 smooth transparent (SmT) or smooth opaque (SmO) (A) or M. avium strain SE01 (B). The number of intracellular viable bacteria correlated to macrophage numbers (relative CFU) was determined 7 days postinfection. Values represent means of duplicates ± SD of one representative experiment out of six. (C and D) Results obtained from different donors. Macrophages were preincubated with 10 µM MAP kinase inhibitor or 0.1% (vol/vol) DMSO. Cells were infected with 2151 SmT or 2151 SmO (C) or with SE01 (D). For each donor, CFU counts 7 days postinfection were correlated to macrophage numbers and are shown as relative CFU. The boxes indicate the 25th and 75th percentiles. Whiskers above and below the boxes indicate the 90th and 10th percentiles. Medians are marked. All outlying points are graphed. Data shown were obtained from six independent experiments (six different donors) performed in duplicate. *, P < 0.05; n.s., not significant.
